Performance Max is the campaign type Google most wants medical practices to use and the one that requires the most caution before adopting. The pitch is automation. The reality is loss of control in places that matter.
Google’s Performance Max campaign type has been pushed harder than any other product in the Ads platform over the past several years. Account representatives recommend it. Optimization scores reward it. Bidding flows nudge toward it. The pitch is that machine learning, given access to all of Google’s inventory and minimal constraints, will produce better results than tightly controlled campaigns built by humans.
Sometimes it does. For some advertisers, in some contexts, Performance Max produces results that match or exceed traditional campaign structures. For medical practices specifically, the results are more uneven, and the cases where Performance Max quietly fails outnumber the cases where it clearly wins. Understanding when to use it, and where its weaknesses appear, is one of the practical paid-advertising decisions practice owners face this year.
What Performance Max Actually Is
Performance Max — abbreviated as PMax — is a campaign type that runs across all of Google’s advertising inventory. A single PMax campaign can serve ads on Search, Display, YouTube, Discover, Gmail, and Maps simultaneously. The advertiser provides creative assets, conversion goals, and a budget. Google’s algorithms decide where the ads run, who sees them, and how bids are allocated.
The appeal is consolidation and automation. Instead of managing separate campaigns for each channel, the advertiser runs one campaign and lets Google handle the optimization across them. For lean teams and accounts with high-volume conversion data, this can simplify management substantially.
The cost of that consolidation is reduced visibility and control. The advertiser sees less detail about which placements drove which conversions, has limited ability to exclude poor-performing placements, and depends on Google’s optimization decisions in ways that traditional campaigns do not.
Where Performance Max Works for Healthcare
There are specific contexts where Performance Max performs well for medical practices.
Practices with strong, well-defined conversion data — meaningful conversion volume, clear conversion values, and accurate first-party data feeding the account — give the algorithm enough signal to optimize meaningfully. PMax is, fundamentally, a machine learning product, and machine learning needs data. Accounts with thin conversion data tend to underperform in PMax because the algorithm cannot learn quickly enough to outperform a well-structured traditional campaign.
Practices in higher-volume specialties with broader patient bases tend to fit PMax better than highly specialized practices targeting narrow niches. The algorithm’s strengths in cross-channel optimization show up more clearly when there is a substantial audience to optimize against.
Brand awareness goals fit PMax better than direct response goals for many healthcare contexts. The cross-channel reach the campaign type provides is well-suited to building visibility across multiple touchpoints, even when individual conversion attribution is harder to nail down.
Where Performance Max Quietly Fails
Several common failure modes affect medical practice PMax campaigns, and most of them are not visible from the surface metrics.
Cannibalization of branded search is the most common problem. PMax campaigns frequently capture branded queries — patients searching for the practice by name — and report those captures as conversions, even though the patient would have found the practice organically anyway. The campaign’s reported performance looks strong; the incremental value to the practice is negligible.
Detection of this requires comparing pre-PMax branded search volume with post-PMax branded search performance, and the comparison is rarely run. Practices launch PMax, see strong conversion numbers, and conclude the campaign is working. The branded conversions are usually a meaningful share of the reported total.
Placement quality varies widely. PMax serves on the Display Network, where placement quality can range from premium publishers to low-quality apps and games that happen to be running display inventory. For healthcare, where brand association matters, the placement distribution can include contexts the practice would never have selected manually.
Limited visibility into search term performance. PMax’s search-term reporting is less detailed than traditional Search campaigns. The advertiser sees less of what queries are actually triggering ads, which means problematic queries — wrong intent, wrong specialty, sensitive topics — can run for extended periods before being identified.
Asset feed problems. PMax depends heavily on the creative assets the advertiser provides, and the algorithm’s combinations of those assets can produce unintended messaging. An asset combination might pair a clinical image with copy intended for a different service, producing ads the practice would not have approved if shown manually.
Conflict with restricted category policies. Healthcare advertising falls under restricted categories that PMax’s algorithm does not always interpret cleanly. Campaigns that should have been confined to certain placement types or audience profiles sometimes serve outside those bounds because the algorithm’s interpretation of the restrictions is opaque.
The Attribution Problem
Beyond placement and creative concerns, PMax presents a deeper attribution challenge for medical practices.
Healthcare patient journeys are long. A patient may encounter the practice through a YouTube ad, see retargeting on Display, search for the practice on Google, and finally convert through a branded search result. PMax claims credit for the conversion based on Google’s internal attribution model, which may or may not align with how the practice thinks about which channels actually drove the outcome.
The result is that PMax campaigns often appear to be the highest-performing channel in the account, while the underlying truth is that the conversions would have happened through other channels and PMax was the final touch. The reported ROAS is excellent. The incremental ROAS — the value PMax actually added — is often much lower.
Practices that have not run incrementality testing on PMax sometimes invest heavily in it based on reported performance, and later discover that pulling PMax budget produces a much smaller drop in total conversions than expected. The conversions were happening anyway.
How to Use Performance Max Cautiously
For practices that want to test PMax, a careful approach reduces the failure modes.
Use brand exclusions. PMax allows excluding branded keywords from its targeting, which prevents the most common cannibalization pattern. Configuring brand exclusions at campaign launch is a small step that prevents misleading attribution.
Use placement exclusions where the platform allows. Display placements that the practice would not approve manually can sometimes be excluded at the account level, reducing the risk of unsuitable contexts.
Use restrictive asset groups. PMax allows configuring asset groups with tighter targeting parameters. For healthcare, asset groups built around specific service lines, with carefully selected creative and audience signals, perform better than broad asset groups that let the algorithm explore widely.
Use incrementality testing. Before scaling PMax investment, run an incrementality test — pause the campaign for a defined period and compare total conversions during and after. If pausing PMax produces a small drop in conversions, the campaign’s reported performance is overstated. If pausing produces a large drop, the campaign is genuinely contributing.
Use it alongside traditional campaigns, not instead of them. The most resilient structure tends to be a foundation of well-built Search campaigns covering branded and high-intent non-branded queries, with PMax layered on top for incremental reach. This structure preserves visibility and control where they matter most while testing PMax’s contribution at the margin.
The Decision Worth Making Carefully
Performance Max is not bad. It is a tool that fits some contexts and fails in others, and Google’s marketing makes it sound more universally appropriate than the evidence supports.
For medical practices, the right approach is skepticism balanced with willingness to test. Run PMax with brand exclusions, careful asset configuration, and incrementality testing. Evaluate the actual incremental value rather than the reported attribution. Keep it as a layer in the campaign mix rather than a replacement for the foundational campaigns that provide visibility and control.
The practices that approach PMax this way get the parts of it that work without the parts that quietly fail. The practices that adopt it wholesale, based on Google’s recommendations and the surface-level performance reports, often find later that the campaign was less valuable than it appeared.
